Parameter

Reference range

Study foods

n

0 W

2 W

4 W

6 W

mean ± SD

p value 1

mean ± SD

p value 1

p value 2

mean ± SD

p value 1

p value 2

mean ± SD

p value 1

p value 2

White blood cell count (/μL)

3300 - 9000

LC-Plasma

20

5270 ± 1025

0.105

5360 ± 1161

0.275

0.605

5420 ± 1363

0.220

0.548

5205 ± 1025

0.255

0.676

Placebo

20

5860 ± 1212

5865 ± 1677

0.985

6095 ± 2000

0.346

5680 ± 1526

0.430

Red blood cell count (×10⁴/μL)

M: 430 - 570 F: 380 - 500

LC-Plasma

20

472.6 ± 38.7

0.692

477.7 ± 37.7

0.223

0.209

466.8 ± 35.1

0.745

0.203

466.9 ± 39.8

0.836

0.189

Placebo

20

468.1 ± 32.3

463.7 ± 33.4

0.161

463.1 ± 35.4

0.344

469.3 ± 34.4

0.774

Hemoglobin (g/dL)

M: 13.5 - 17.5 F: 11.5 - 15.0

LC-Plasma

20

14.3 ± 1.4

0.730

14.5 ± 1.3

0.523

0.118

14.2 ± 1.3

0.907

0.709

14.2 ± 1.4

0.865

0.360

Placebo

20

14.4 ± 1.3

14.2 ± 1.3

0.023

14.2 ± 1.4

0.141

14.2 ± 1.3

0.074

Hematocrit (%)

M: 39.7 - 52.4 F: 34.8 - 45.0

LC-Plasma

20

44.4 ± 3.7

0.634

44.4 ± 3.2

0.285

0.919

44.9 ± 3.3

0.840

0.279

44.4 ± 3.9

0.937

0.881

Placebo

20

43.8 ± 3.3

43.3 ± 3.2

0.056

44.7 ± 3.5

0.082

44.5 ± 3.6

0.106

Platelet count (×10⁴/μL)

14.0 - 34.0

LC-Plasma

20

27.5 ± 5.8

0.977

28.1 ± 5.1

0.377

0.244

26.9 ± 4.8

0.920

0.282

27.9 ± 4.6

0.980

0.492

Placebo

20

27.6 ± 3.8

26.9 ± 3.8

0.220

26.8 ± 4.0

0.106

28.0 ± 4.2

0.382

MCV (fl)

85 - 102

LC-Plasma

20

94.0 ± 4.1

0.791

93.3 ± 4.8

0.840

0.036

96.3 ± 4.8

0.877

0.000

95.3 ± 4.5

0.744

0.000

Placebo

20

93.7 ± 2.9

93.5 ± 2.7

0.428

96.5 ± 3.1

0.000

94.9 ± 3.1

0.000

MCH (pg)

28.0 - 34.0

LC-Plasma

20

30.3 ± 1.7

0.238

30.4 ± 1.7

0.495

0.207

30.5 ± 1.7

0.841

0.010

30.3 ± 1.6

0.974

0.557

Placebo

20

30.8 ± 1.3

30.7 ± 1.2

0.070

30.6 ± 1.2

0.020

30.3 ± 1.2

0.000

MCHC (%)

30.2 - 35.1

LC-Plasma

20

32.2 ± 1.0

0.016

32.6 ± 1.1

0.522

0.000

31.7 ± 0.8

0.915

0.001

31.8 ± 0.8

0.645

0.017

Placebo

20

32.9 ± 0.9

32.8 ± 0.8

0.276

31.7 ± 0.9

0.000

31.9 ± 0.7

0.000

NEUT/leukocyte fractionation (%)

40.0 - 75.0

LC-Plasma

20

54.4 ± 8.3

0.661

54.7 ± 7.1

0.559

0.860

56.6 ± 8.4

0.774

0.290

55.2 ± 6.2

0.662

0.594

Placebo

20

55.4 ± 6.5

56.0 ± 7.2

0.666

55.9 ± 8.2

0.761

56.3 ± 8.5

0.647

LYMPH/leukocyte fractionation (%)

18.0 - 49.0

LC-Plasma

20

36.0 ± 6.9

0.798

36.1 ± 6.6

0.632

0.936

34.8 ± 7.9

0.998

0.518

35.6 ± 5.8

0.898

0.756

Placebo

20

35.4 ± 6.6

35.0 ± 7.7

0.709

34.8 ± 7.6

0.632

35.3 ± 8.6

0.925

MONO/leukocyte fractionation (%)

2.0 - 10.0

LC-Plasma

20

6.0 ± 1.0

0.193

5.8 ± 1.4

0.170

0.341

5.2 ± 1.5

0.786

0.011

5.7 ± 1.2

0.018

0.200

Placebo

20

5.4 ± 1.4

5.3 ± 1.1

0.488

5.3 ± 1.4

0.723

4.9 ± 0.9

0.045

EOSINO/leukocyte fractionation (%)

0.0 - 8.0

LC-Plasma

20

3.1 ± 2.1

0.929

3.0 ± 2.0

0.759

0.379

3.0 ± 2.2

0.649

0.577

3.0 ± 1.6

0.986

0.582

Placebo

20

3.1 ± 2.1

3.2 ± 2.2

0.710

3.3 ± 2.2

0.222

3.0 ± 2.0

0.580

BASO/leukocyte fractionation (%)

0.0 - 2.0

LC-Plasma

20

0.5 ± 0.2

0.278

0.5 ± 0.2

0.326

1.000

0.4 ± 0.3

0.018

0.064

0.6 ± 0.4

0.384

0.838

Placebo

20

0.6 ± 0.3

0.6 ± 0.4

0.852

0.7 ± 0.4

0.269

0.6 ± 0.3

0.759